Is there a role for cytoreductive nephrectomy?
This discussion with Dr Paul Russo presents a case for [...]
Despite promising new regimens, search for cure is ‘highest priority’ in advanced renal cell carcinoma
This review, published in HemOnc Today this week, discusses the [...]
The role of biomarkers in predicting response to treatment in metastatic kidney cancer
This review published in Clinical Genitourinary Cancer summarises the current [...]
The role of cytoreductive nephrectomy in metastatic kidney cancer
Around 12,500 new cases of renal cell carcinoma (RCC) are [...]
Elderly kidney cancer patients benefit from targeted therapies
Elderly patients with metastatic renal cell carcinoma (RCC) are often [...]
PD-1 and CTLA-4 as biomarkers for survival in kidney cancer
A recent study published in Journal of Clinical Medicine last [...]
Cytoreductive surgery with immunotherapy for kidney cancer patients
In this video clip, Professor Eric Jonasch, Medical Oncologist, Division [...]
Radical versus partial nephrectomy and subsequent hypertension risk
In a recent study, the data from a database were [...]
Nivolumab-ipilimumab combination shows promise for kidney cancer brain metastases
An interim analysis of study Checkmate 920 has shown that [...]
Genetic mutations associated with survival in immunotherapy-treated kidney cancer patients
A recent study of patients with solid tumours treated with [...]
